InterMune Inc (ITMN)

73.89
0.02 0.03
NASDAQ : Health Care
Prev Close 73.91
Open 73.91
Day Low/High 73.81 / 73.99
52 Wk Low/High 10.95 / 74.24
Volume 5.72M
Avg Volume 3.94M
Exchange NASDAQ
Shares Outstanding 107.97M
Market Cap 7.98B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Slump Continues With All S&P 500 Sectors in Negative Territory

Stocks Slump Continues With All S&P 500 Sectors in Negative Territory

The Dow Jones index of blue-chip stocks climbed to within 19 points of the 20,000 milestone on Wednesday before falling backward. The Nasdaq slid from a record opening of 5,499.

Hacking Case Shows Mounting Risk for M&A Law Firms, Corporate Clients

Hacking Case Shows Mounting Risk for M&A Law Firms, Corporate Clients

Law firms specializing in mergers and acquisitions will need to hire consultants to help them set up tougher security systems, perhaps modeled after those of investment banks.

Stocks Turn Negative, Prolonging Dow's Trek Toward 20,000

Stocks Turn Negative, Prolonging Dow's Trek Toward 20,000

The Dow Jones index of 30 blue-chip stocks climbed to within 19 points of the milestone on Wednesday before retreating. The Nasdaq slid from a record opening of 5,499.

Stock Futures Continue Climb With Potential for Record-Setting Day

Stock Futures Continue Climb With Potential for Record-Setting Day

Stock futures move higher Wednesday morning as Wall Street readies for what may be another record-setting day.

U.S. Charges 3 Chinese Nationals With Insider Trading, Hacking Law Firms

U.S. Charges 3 Chinese Nationals With Insider Trading, Hacking Law Firms

Feds, SEC accuse Chinese IT company workers of hacking into law firms and of insider trading involving companies in mergers.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures are rising moderately and may finally be ready to surpass the Dow 20,000 mark; the government charges three Chinese nationals with hacking and insider trading.

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

If history repeats itself, the recent weakness in biotech stocks will end with lots more buying.

Health Care Stocks: A Year in Review and Predictions for 2015

Health Care Stocks: A Year in Review and Predictions for 2015

In 2014 drugmakers long on cash but short on growth bought quick access to markets that would have otherwise taken years to build. Can this continue?

Why Roche (RHHBY) Stock Is Up Today

Why Roche (RHHBY) Stock Is Up Today

CEO Schwan told Reuters that the company's decision to buy U.S. biotech company InterMune (ITMN) was "exceptional" and not a sign of more ambitious plans for major acquisitions.

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Small-cap stocks are experiencing selling pressure this week as volatility rises as world event prey on investor uncertainty.

InterMune Larger Than S&P 500 Component D.R. Horton

InterMune Larger Than S&P 500 Component D.R. Horton

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component InterMune Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example D.

INTERMUNE SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices Of Vincent Wong Investigates The Sale Of InterMune, Inc. To Roche Holding AG

INTERMUNE SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices Of Vincent Wong Investigates The Sale Of InterMune, Inc. To Roche Holding AG

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc.

INTERMUNE INVESTOR ALERT: Faruqi & Faruqi, LLP Is Investigating The Board Of Directors Of InterMune, Inc. (ITMN) In Relation To The Proposed Sale Of The Company To Roche Holdings, Inc.

INTERMUNE INVESTOR ALERT: Faruqi & Faruqi, LLP Is Investigating The Board Of Directors Of InterMune, Inc. (ITMN) In Relation To The Proposed Sale Of The Company To Roche Holdings, Inc.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of InterMune, Inc.

Roche, InterMune a Strategic Play in Midst of Inversions

Roche, InterMune a Strategic Play in Midst of Inversions

As more companies seek tax savings through inversions, strategic reasons still remain for drug company deals.

INVESTOR ALERT – InterMune, Inc.: The Law Offices Of Vincent Wong Investigates The Sale Of InterMune, Inc. To Roche Holding AG

INVESTOR ALERT – InterMune, Inc.: The Law Offices Of Vincent Wong Investigates The Sale Of InterMune, Inc. To Roche Holding AG

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc.

Why InterMune (ITMN) Stock Is Gaining Today

Why InterMune (ITMN) Stock Is Gaining Today

InterMune (ITMN) shares are up on heavy trading, one day after the company agreed to be bought by Roche for $8.3 billion.

Jim Cramer's 'Mad Money' Recap: Thank You, Corporate America

Jim Cramer's 'Mad Money' Recap: Thank You, Corporate America

Corporate profits, not the Fed, are fueling ever higher stock prices, and that growth is only accelerating, Cramer says.

INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of InterMune, Inc. Over The Proposed Sale Of The Company To Roche Holdings, Inc. - ITMN

INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of InterMune, Inc. Over The Proposed Sale Of The Company To Roche Holdings, Inc. - ITMN

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Intermune, Inc.

Summer Rally Contiues on Lower Volume

Summer Rally Contiues on Lower Volume

We remain in a strong market that has yet to show any sign of stopping.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of InterMune, Inc. In Connection With The Proposed Sale Of The Company To Roche Holdings, Inc.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of InterMune, Inc. In Connection With The Proposed Sale Of The Company To Roche Holdings, Inc.

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...